Valuation : Getinge AB

Market Cap 6.62TCr 690.55Cr 595.67Cr 560.32Cr 510.46Cr 959.91Cr 66TCr 965.11Cr 2.58TCr 33TCr 2.59TCr 2.54TCr 1,10500Cr P/E 2026 *
21.2x
P/E 2027 * 19.1x
Enterprise Value 7.48TCr 779.4Cr 672.31Cr 632.42Cr 576.14Cr 1.08TCr 74TCr 1.09TCr 2.91TCr 38TCr 2.93TCr 2.86TCr 1,24800Cr EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.95x
Free-Float
79.13%
Yield 2026 *
2.16%
Yield 2027 * 2.32%
1 week-0.59%
1 month+1.76%
3 months+24.45%
6 months+15.26%
Current year+8.40%
1 week 21.84
Extreme 21.84
22.28
1 month 21.52
Extreme 21.52
22.28
3 years 14.2
Extreme 14.2
22.28
5 years 14.2
Extreme 14.2
43.02
10 years 0
Extreme 0
43.02
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.59%+16.67%+36.70% 693.44Cr
-0.16%-0.36%+18.32%+21.96% 1.27TCr
-0.29%-0.73%+17.37%+27.76% 693.44Cr
+0.72%-6.25%+49.72%+27.97% 626.12Cr
+10.66%+12.44% - - 568.99Cr
+1.85%-3.43%-12.20%+46.03% 507.63Cr
+0.65%+0.62%-30.15%-22.88% 384.87Cr
-1.53%+3.70%+40.96%-21.21% 205.53Cr
+0.83%+11.99%-13.16%+134.36% 178.08Cr
+2.08%+2.57%+51.33%-13.08% 160.02Cr
Average +1.71%+1.20%+15.43%+26.40% 510.82Cr
Weighted average by Cap. +1.71%-0.18%+15.79%+25.88%

Financials

2026 *2027 *
Net sales 3.52TCr 367.21Cr 316.75Cr 297.95Cr 271.44Cr 510.44Cr 35TCr 513.21Cr 1.37TCr 18TCr 1.38TCr 1.35TCr 59TCr 3.72TCr 387.54Cr 334.29Cr 314.46Cr 286.48Cr 538.71Cr 37TCr 541.63Cr 1.45TCr 19TCr 1.46TCr 1.42TCr 62TCr
Net income 313.88Cr 33Cr 28Cr 27Cr 24Cr 45Cr 3.11TCr 46Cr 122.17Cr 1.58TCr 122.85Cr 120.19Cr 5.24TCr 346.49Cr 36Cr 31Cr 29Cr 27Cr 50Cr 3.43TCr 50Cr 134.86Cr 1.74TCr 135.62Cr 132.68Cr 5.78TCr
Net Debt 852.34Cr 89Cr 77Cr 72Cr 66Cr 123.51Cr 8.43TCr 124.18Cr 331.75Cr 4.29TCr 333.61Cr 326.37Cr 14TCr 631.08Cr 66Cr 57Cr 53Cr 49Cr 91Cr 6.24TCr 92Cr 245.63Cr 3.18TCr 247.01Cr 241.65Cr 11TCr
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
02/26/02 21.94 0.00%
31/26/31 €21.94 -1.26%
28/26/28 €22.22 +0.54%
27/26/27 €22.10 +0.23%
26/26/26 €22.05 +0.05%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
243.90SEK
Average target price
240.11SEK
Spread / Average Target
-1.55%

Quarterly revenue - Rate of surprise